The deterministic health profile is critically weak, headlined by a Piotroski F-Score of 1/9, indicating severe fundamental deterioration. While the current P/E of 1.60 appears attractive, the jump to a Forward P/E of 21.14 suggests a massive expected collapse in earnings or a non-recurring gain in the trailing period. Technical trends are overwhelmingly bearish (10/100), and the lack of dividend strength or growth metrics further undermines the investment case. The asset exhibits characteristics of a fixed-income instrument rather than growth equity, but based on the provided scorecard, it is fundamentally distressed.